STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
Zhang C, Wang X, Fang D, Xu P, Mo X, Hu C, Abdelatty A, Wang M, Xu H, Sun Q, Zhou G, She J, Xia J, Hui KM, Xia H.
Zhang C, et al. Among authors: fang d.
Theranostics. 2021 Jan 1;11(5):2108-2122. doi: 10.7150/thno.48112. eCollection 2021.
Theranostics. 2021.
PMID: 33500714
Free PMC article.